Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Stewart Benton

Interventional Cardiology York, PA Medical Doctor

NPI 1386930097 CMS profile 1384226

30 Monument Rd, Suite 1100, York, PA 17403

Open in the dashboard

General payments

$230,292

473 records reported · program years 2019–2025

Research payments

$6,375

Paid to them · 12 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$137,351 paid to institutions, not to them · program years 2021–2025

Through program year 2025, Stewart Benton of York, PA is reported in the CMS Open Payments database as having received $230,292 across 473 general payments and $6,375 in research payments paid to them. Separately, studies naming them as principal investigator received $137,351 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 96th percentile of Interventional Cardiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

9 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $34,891 49
2024 General $37,078 88
2023 General $42,136 99
2022 General $35,708 77
2022 Research $2,625 7
2021 General $49,246 40
2021 Research $3,750 5
2020 General $26,226 59
2019 General $5,008 61

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Stewart Benton
  • Interventional Cardiology median
  • Middle half of Interventional Cardiology
  • National median

In program year 2025, general payments to Stewart Benton were reported at $34,891. Among 6,173 Interventional Cardiology profiles paid that year, the median was $1,092 and the middle half received between $366 and $3,019.

Show as a table
Year Stewart Benton Interventional Cardiology median Middle half National median
2019 $5,008 $1,097 $329–$3,048 $163
2020 $26,226 $473 $161–$1,480 $114
2021 $49,246 $677 $233–$1,827 $132
2022 $35,708 $978 $333–$2,724 $149
2023 $42,136 $1,136 $382–$2,986 $160
2024 $37,078 $1,181 $395–$3,326 $164
2025 $34,891 $1,092 $366–$3,019 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Boston Scientific Corporation $132,423 229 payments
  2. Baylis Medical Company Inc $37,000 6 payments
  3. Medtronic Vascular, Inc. $26,763 67 payments
  4. Medtronic, Inc. $14,233 44 payments
  5. Canon Medical Systems USA, Inc. $7,641 5 payments
  6. Siemens Medical Solutions USA, Inc. $4,084 37 payments
  7. Shockwave Medical, Inc $2,288 5 payments
  8. Abbott Laboratories $1,908 24 payments
  9. HeartFlow, Inc. $1,216 16 payments
  10. Edwards Lifesciences Corporation $993 12 payments
  11. Other $1,743 28 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $133,995 51 payments
  2. Consulting Fee $55,188 12 payments
  3. Travel and Lodging $21,724 86 payments
  4. Food and Beverage $14,864 321 payments
  5. Honoraria $2,500 1 payment
  6. Compensation for serving as faculty or as a speaker for a medical education program $2,000 1 payment
  7. Education $21 1 payment
Products named General payments · program years 2019–2025
  1. VersaCross Access Solution Icg $37,000 6 payments
  2. CoreValve Evolut Transcatheter Valve Systems $26,722 64 payments
  3. VersaCross Access Solution Icg $26,129 11 payments
  4. General - Vascular Access General - Vascular Access_IC $23,711 9 payments
  5. WATCHMAN FLX $7,479 17 payments
  6. CoreValve Evolut Transcatheter Valve Systems $7,160 8 payments
  7. COREVALVE EVOLUT R $6,277 21 payments
  8. GENERAL - VASCULAR ACCESS Vascular $5,904 4 payments
  9. INTERVENTIONAL ANGIOGRAPHY SYSTEM $5,000 2 payments
  10. Vascular $2,500 1 payment
  11. Other $22,864 262 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Medtronic, Inc. $6,375 12 payments

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

28

Median for Interventional Cardiology: 2,236

Drug cost

$426

Median for Interventional Cardiology: $380,412

Branded share of claims

100%

Median for Interventional Cardiology: 27.8%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Clopidogrel Clopidogrel Bisulfate Brand 28 $426

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 4,694 Part D prescribers listed as Interventional Cardiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 50 billing codes

Paid by Medicare

$164,902

Medicare's payments for the services billed

Medicare patients

359

Average age 77

Services billed

871

134 women, 225 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 75%
Atrial fibrillation 64%
Heart failure 62%
Arthritis 55%
Diabetes 49%
Chronic kidney disease 45%
Depression 31%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

485 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Interventional Cardiology in Pennsylvania

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record